NO20000293L - Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner - Google Patents

Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner

Info

Publication number
NO20000293L
NO20000293L NO20000293A NO20000293A NO20000293L NO 20000293 L NO20000293 L NO 20000293L NO 20000293 A NO20000293 A NO 20000293A NO 20000293 A NO20000293 A NO 20000293A NO 20000293 L NO20000293 L NO 20000293L
Authority
NO
Norway
Prior art keywords
local anesthetic
methods
headaches
muscular
patient
Prior art date
Application number
NO20000293A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000293D0 (no
Inventor
Bruce H Levin
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO20000293D0 publication Critical patent/NO20000293D0/no
Publication of NO20000293L publication Critical patent/NO20000293L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20000293A 1997-07-21 2000-01-20 Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner NO20000293L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89719297A 1997-07-21 1997-07-21
US7284598P 1998-01-28 1998-01-28
US8455998P 1998-05-06 1998-05-06
PCT/US1998/014870 WO1999003473A1 (fr) 1997-07-21 1998-07-17 Compositions, kits et procedes permettant d'inhiber des troubles cerebraux neurovasculaires et des cephalees musculaires

Publications (2)

Publication Number Publication Date
NO20000293D0 NO20000293D0 (no) 2000-01-20
NO20000293L true NO20000293L (no) 2000-03-20

Family

ID=27372174

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000293A NO20000293L (no) 1997-07-21 2000-01-20 Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner

Country Status (20)

Country Link
EP (1) EP0999839B1 (fr)
JP (1) JP4521117B2 (fr)
KR (1) KR20010022041A (fr)
CN (1) CN1267219A (fr)
AR (1) AR013240A1 (fr)
AT (1) ATE269702T1 (fr)
AU (1) AU8574398A (fr)
BR (1) BR9810773A (fr)
CA (1) CA2297097C (fr)
DE (1) DE69824730T2 (fr)
EE (1) EE200000050A (fr)
HU (1) HUP0003953A3 (fr)
ID (1) ID24903A (fr)
IL (2) IL134087A0 (fr)
IS (1) IS5349A (fr)
NO (1) NO20000293L (fr)
PL (1) PL338176A1 (fr)
SK (1) SK187899A3 (fr)
TR (1) TR200000149T2 (fr)
WO (1) WO1999003473A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP4632499B2 (ja) * 1999-08-26 2011-02-16 武田薬品工業株式会社 鼻粘膜付着マトリックス
AU2100901A (en) * 1999-12-15 2001-06-25 Bruce H. Levin Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US7120489B2 (en) 2000-05-08 2006-10-10 Brainsgate, Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the BBB and cerebral blood flow
US7146209B2 (en) 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US7117033B2 (en) 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US7636597B2 (en) 2002-11-14 2009-12-22 Brainsgate, Ltd. Surgical tools and techniques for stimulation
US7561919B2 (en) 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
US7769461B2 (en) 2003-12-19 2010-08-03 Boston Scientific Neuromodulation Corporation Skull-mounted electrical stimulation system and method for treating patients
US8010189B2 (en) 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
EP1782831B1 (fr) * 2004-08-18 2011-10-19 Medrx Co., Ltd. Preparation a usage externe
BRPI0916323A2 (pt) * 2008-07-21 2018-05-29 Otonomy Inc composições antimicrobianas de liberação controlada e métodos para o tratamento de distúrbios do ouvido
DE102008037682A1 (de) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
WO2014052859A1 (fr) 2012-09-28 2014-04-03 St. Renatus, Llc Composition pharmaceutique d'alcool benzylique pour le traitement des migraines
CN103432378A (zh) * 2013-08-15 2013-12-11 吕清华 一种治疗神经血管性头痛的中药
EP2878335B1 (fr) 2013-11-10 2018-01-03 Brainsgate Ltd. Implant et système d'implantation pour stimulateur neural
US10271907B2 (en) 2015-05-13 2019-04-30 Brainsgate Ltd. Implant and delivery system for neural stimulator
EP3897603A4 (fr) * 2018-12-19 2022-09-14 Grace Therapeutics Inc. Composition thérapeutique de lidocaïne intranasale
US20220096452A1 (en) * 2019-01-22 2022-03-31 Icm (Institut Du Cerveau Et De La Moelle Épinière) Local anesthetic for the treatment of neurological symptoms resulting from brain dysfunctions
GB2628149A (en) * 2023-03-16 2024-09-18 Lee Nathaniel Wurie Nasal spray for performing sphenopalatine ganglion block

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
DE19526019A1 (de) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Kopfschmerzen
BE1009851A3 (fr) * 1996-01-11 1997-10-07 Thiebauld Charles Marie Composition pharmaceutique pour le traitement des cephalees et son utilisation.
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
CA2297097C (fr) 2009-04-07
AU8574398A (en) 1999-02-10
TR200000149T2 (tr) 2000-05-22
DE69824730T2 (de) 2005-07-14
JP2001513483A (ja) 2001-09-04
ID24903A (id) 2000-08-31
DE69824730D1 (de) 2004-07-29
HUP0003953A3 (en) 2002-02-28
IL134087A0 (en) 2001-04-30
EE200000050A (et) 2000-10-16
SK187899A3 (en) 2000-12-11
CA2297097A1 (fr) 1999-01-28
ATE269702T1 (de) 2004-07-15
WO1999003473A1 (fr) 1999-01-28
NO20000293D0 (no) 2000-01-20
AR013240A1 (es) 2000-12-13
IS5349A (is) 2000-01-18
CN1267219A (zh) 2000-09-20
HUP0003953A1 (hu) 2002-01-28
IL134087A (en) 2006-10-31
EP0999839B1 (fr) 2004-06-23
EP0999839A1 (fr) 2000-05-17
KR20010022041A (ko) 2001-03-15
JP4521117B2 (ja) 2010-08-11
BR9810773A (pt) 2000-09-19
PL338176A1 (en) 2000-10-09

Similar Documents

Publication Publication Date Title
WO2001062236A3 (fr) Nouvelles combinaisons medicamenteuses
NO980592L (no) Nye opioidpeptider
DK1076657T3 (da) Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
EA200901492A1 (ru) Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов (sarm)
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
NO20056252L (no) Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser
BR0213040A (pt) Composto, processo para preparar um composto, e, método de tratar doenças
BR9806157A (pt) Composições farmacêuticas de descarboetoxiloratadina anidras, não higroscópicas e sem lactose
AR013240A1 (es) Composiciones, equipos y metodos para inhibir los deseordenes neurovasculares cerebrales y los dolores de cabeza musculares
NO954878L (no) Pyrrolderivater
WO2001043733A3 (fr) Compositions, trousses, appareil et procedes utiles pour inhiber l'inflammation cephalique
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
EE04491B1 (et) (+)-nortsisapriidi kasutamine
NO992062L (no) Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel
SE9603725D0 (sv) New teatment
MX9701820A (es) Compuestos de pirazolo [3,4-g] quinoxalina que inhiben proteina tirosina quinasa receptora de pdgf.
EP1064966A3 (fr) Combinaisons d'agonistes de recepteurs de 5HT 1, de cafeine et d'inhibiteurs de cyclooxygenase-2 pour le traitement de la migraine
HK1051485A1 (zh) 增生性疾病的治療
WO2001030331A3 (fr) Compositions therapeutiques comprenant des inhibiteurs de la proteine kinase c
MXPA02010184A (es) Formulaciones topicas para el suministro transdermico de niacina y metodos para tratar hiperlipidemia.
SE9702066D0 (sv) A new salt
HUP0203050A2 (hu) Endometriózis és meddőség kezelésére, valamint a termékenység fokozására alkalmas gyógyszerkészítmények

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application